The FDA clearance aids AstraZeneca and Daiichi Sankyo’s plan to position ADCs like Enhertu ahead of chemotherapy in a variety ...

New approval brings the medicine to an earlier treatment setting and a broader patient population.

An upstart biopharma firm founded by two former executives at CinCor Pharma – which celebrated a $1.8B exit to AstraZeneca in ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

The Japanese pharma had one asset rejected by the FDA and withdrew a regulatory application for another, but already this ...

MULTINATIONAL pharmaceutical firm AstraZeneca (AZ) wants to conduct the majority of its clinical trials in the Philippines, ...

AstraZeneca will expand the its global R&D hub in Mississauga. This $820 million investment underscores Ontario ’s growing ...

AstraZeneca is expanding its boot print in Canada with a $570 million investment designed to create 700 jobs. | AstraZeneca is expanding its boot print in Canada with a $570 million investment ...

The approval was based on results from the TROPION-Breast01 Phase III trial.

Funding for climate tech has contracted in recent years. What makes Gothenburg so unique in its ability to fund, scale and ...

Claims of QuantumScape’s ex-CEO Jagdeep Singh earning Rs 48 crore daily are false, as verified through official documents and company statements. Pravrajya Suruchi Updated : Jan 10, 2025, 12:00 AM IST ...

Biogen CEO Christopher Viehbacher made similar remarks later on Tuesday during a presentation at the J.P. Morgan Healthcare Conference. “We're not necessarily saying, ‘Hey, wow … we need to go do a ...